Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL

Authors

Matthew J. Wieduwilt, University of Oklahoma
Geoffrey L. Uy, Washington University School of Medicine in St. Louis
et al

Journal

Blood Advances

Publication Date

11-18-2021

Volume

5

Issue

22

First Page

4691

Last Page

4700

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2021004813

Rights and Permissions

Matthew J. Wieduwilt, Jun Yin, Meir Wetzler, Geoffrey L. Uy, Bayard L. Powell, Jonathan E. Kolitz, Michaela Liedtke, Wendy Stock, Jan H. Beumer, Ryan J. Mattison, Elizabeth Storrick, Susan M. Christner, Lionel D. Lewis, Steven Devine, Richard M. Stone, Richard A. Larson; Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL. Blood Adv 2021; 5 (22): 4691–4700. doi: https://doi.org/10.1182/bloodadvances.2021004813 Copyright 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Wieduwilt, Matthew J.; Uy, Geoffrey L.; and et al, "Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL." Blood Advances. 5, 22. 4691 - 4700. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11090